Ambulatory surgery centers sell for 6x to 12x EBITDA, measuring earnings before interest, taxes, depreciation, and amortization — the annual operating profit from surgical procedure facility fees and ancillary services. Centers with growing case volumes, high-value specialty mixes, committed surgeon-investors, comprehensive payer contracts, and modern facilities consistently achieve the upper range. The wide valuation spread reflects the specialty economics, physician relationships, and payer positioning that buyers evaluate when pricing ASC acquisitions.

Case volume and growth trajectory provide the foundational revenue metric because they measure how effectively the center converts its surgical capacity into performed procedures. Centers performing 5,000+ annual cases across multiple operating rooms demonstrate sustained physician utilization and patient demand. Annual case growth of 5-10% signals expanding surgeon commitment and market opportunity. Operating room utilization rates above 70% indicate efficient scheduling without significant idle capacity. Buyers model case volume by individual surgeon and specialty to identify concentration risks, growth opportunities, and the impact of potential physician departures on forward revenue projections.

Specialty mix determines average revenue per case and EBITDA margin, creating the largest single revenue quality variable. Orthopedic procedures including total joint replacement, spine surgery, and sports medicine generate facility fees of $5,000-15,000 per case compared to $1,500-3,000 for gastroenterology and ophthalmology. A center performing 3,000 orthopedic cases generates substantially more revenue than a center performing 3,000 GI procedures despite identical case counts. Multi-specialty centers serving orthopedics, pain management, ENT, general surgery, and ophthalmology diversify revenue sources while maintaining exposure to high-reimbursement procedures, applying the same diversification principles analyzed in dental practice business valuation for multi-service healthcare operations.

Surgeon commitment is uniquely important in ASC valuation because surgical volume is physician-directed and transfers with the surgeon rather than the facility. Centers with six-plus surgeon-investors contributing equity capital and collectively generating 80%+ of cases demonstrate aligned interests that protect volume continuity during ownership transitions. Physician equity participation creates financial incentive to maintain case volume at the center rather than redirecting procedures to competing facilities. Single-surgeon dependency where one physician generates 40%+ of volume creates material risk that buyers discount 20-30%. Buyers evaluate surgeon demographics, practice trajectories, and binding use agreements or non-compete provisions to project post-acquisition volume retention.

Payer contract coverage determines revenue accessibility and per-case reimbursement rates. In-network status with commercial insurers covering 90%+ of the local insured population ensures the center can serve virtually all physician-referred patients without insurance barriers. Medicare certification enables service to the growing population over age 65 transitioning from inpatient to outpatient surgical settings. Negotiated commercial rates at 150-250% of Medicare benchmark rates for key procedure codes directly impact EBITDA margins. Out-of-network centers face patient access limitations, balance billing restrictions, and reimbursement uncertainty that compresses multiples. Payer mix favoring commercial insurance over Medicare and Medicaid generates higher average reimbursement per case.

Accreditation and regulatory compliance validate clinical quality while enabling full participation in payer networks. AAAHC or Joint Commission accreditation demonstrates voluntary commitment to clinical standards exceeding minimum state licensing requirements. CMS Medicare certification requires meeting detailed Conditions for Coverage spanning facility design, staffing qualifications, quality assurance programming, infection control protocols, and patient rights provisions. Clean survey histories without significant deficiencies reduce regulatory risk that buyers evaluate during diligence. Centers lacking accreditation face restricted commercial payer access because major insurers require accredited facility status for network participation.

Facility and equipment condition determines the capital investment required to maintain surgical capability post-acquisition. Modern operating room suites with current surgical technology, high-definition visualization systems, electrosurgical units, and proper sterile processing infrastructure support the intended specialty case mix. Equipment approaching end-of-life creates replacement requirements of $200K-500K per operating room. Centers with expansion capacity for additional ORs or procedure rooms provide organic growth opportunity through case volume expansion. Buyers evaluate building ownership versus lease terms because facility control affects long-term cost structure and renovation flexibility, as explored in medical practice business valuation benchmarks.

Adjusted EBITDA normalizes physician distributions, management fees, and non-recurring expenses. A center generating $8M in net revenue with $1.6M adjusted EBITDA at 9x values at $14.4M. A comparable center with orthopedic specialization, eight committed surgeon-investors, and comprehensive payer contracts might command 11x, or $17.6M — the $3.2M premium reflects specialty economics and physician commitment. EBITDA margins of 20-35% are typical for well-managed ASCs, with specialty mix and payer rates driving the range.

The buyer landscape includes hospital systems paying 9x-12x EBITDA for ASCs enabling outpatient migration of profitable surgical cases, PE-backed ASC platforms at 8x-11x building multi-site networks, national management companies at 7x-10x expanding geographic coverage, and physician groups at 6x-8x consolidating surgical capacity. Hospital buyers pay premium multiples because ASC acquisition captures outpatient surgical revenue migrating from higher-cost inpatient settings. PE platforms value ASCs as components of multi-site surgical networks achieving administrative and supply chain economies of scale.

Maximizing ASC value before sale involves growing case volume through new surgeon recruitment and specialty expansion, shifting case mix toward higher-reimbursement procedures, securing surgeon equity commitments with documented use agreements, completing in-network contracts with all major regional payers, maintaining current accreditation and clean survey records, and investing in modern surgical equipment. Companies with related healthcare services can reference our veterinary practice business valuation for comparable healthcare facility acquisition benchmarks. Related industries that follow similar consolidation dynamics include Urgent Care Clinic.